Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Oncology Therapeutics Network

Executive Summary

Recent technological upgrades help explain a lower-than-usual 17% growth rate during second quarter, Bristol's Winningham explains. An e-commerce initiative undertaken in 1999 has "been able to help physician's offices carry lower relative inventories of oncology products." Similarly, the installation of 750 dispensing machines in oncologist's offices in the U.S. has reduced inventory levels. The new services, coupled with a lack of new oncology product launches in the first half of 2000, explain the drop-off from 36% growth in 1999, he said

Latest Headlines
See All
UsernamePublicRestriction

Register

PS036426

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel